Title : Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death.

Pub. Date : 2019 Jun 13

PMID : 31196210






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination treatment with curcumin and gefitinib markedly downregulated EGFR activity through suppressing Sp1 and blocking interaction of Sp1 and HADC1, and markedly suppressed receptor tyrosine kinases as well as ERK/MEK and AKT/S6K pathways in the resistant NSCLC cells. Curcumin epidermal growth factor receptor Homo sapiens
2 Curcumin can be used as a sensitizer to enhance the efficacy of EGFR-TKIs and overcome the EGFR-TKI resistance in NSCLC patients with wild-type EGFR and/or KRAS mutation. Curcumin epidermal growth factor receptor Homo sapiens
3 Curcumin can be used as a sensitizer to enhance the efficacy of EGFR-TKIs and overcome the EGFR-TKI resistance in NSCLC patients with wild-type EGFR and/or KRAS mutation. Curcumin epidermal growth factor receptor Homo sapiens
4 Curcumin can be used as a sensitizer to enhance the efficacy of EGFR-TKIs and overcome the EGFR-TKI resistance in NSCLC patients with wild-type EGFR and/or KRAS mutation. Curcumin epidermal growth factor receptor Homo sapiens